CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Barinthus Biopharmaceuticals

For profitWebsite ↗

Also known as: Barinthus Biotherapeutics | Vaccitech Limited | Vaccitech (UK) Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 31, 2024

Timeline

2010s

Jun 1, 2016
Barinthus Biopharmaceuticals— Founded

Drugs by trial phase (15 distinct, 12 trials)

Phase 2 (14 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

vtp-1000

Indications

Studied for

Recent trials (12)

NCT06310291Lead sponsorEarly Phase 1Aug 31, 2024
NCT05617040Lead sponsorPhase 1/Phase 2Dec 31, 2022
NCT05343481Lead sponsorPhase 2Sep 21, 2022
NCT04908111CollaboratorPhase 1/Phase 2Nov 30, 2021
NCT04778904Lead sponsorPhase 1/Phase 2Dec 22, 2020
NCT04607850Lead sponsorPhase 1/Phase 2Nov 30, 2020
NCT03883113Lead sponsorPhase 2Apr 2, 2019
NCT03880474Lead sponsorPhase 2Mar 18, 2019
NCT04297917Lead sponsorPhase 1Feb 10, 2019
NCT03815942CollaboratorPhase 1/Phase 2Dec 10, 2018
NCT03300362Lead sponsorPhase 2Oct 13, 2017
NCT03277456Lead sponsorEarly Phase 1Sep 18, 2017

Details

Founded: Oxford, GB Jun 1, 2016
Last known activity: Aug 31, 2024